Literature DB >> 9030862

A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritis.

S Nityanand1, R Giscombe, S Srivastava, P Hjelmström, C B Sanjeevi, N Sinha, J Grunewald, A K Lefvert.   

Abstract

Takayasu's arteritis (TA) is a chronic large vessel vasculitis with a predilection for the aortic arch and its branches. T lymphocytes may be important in the pathogenesis, as they have been found to infiltrate the vascular lesions. To elucidate further the role of T cells in the disease, we studied circulating CD4+ and CD8+ T cells, expression of the activation marker (HLA-DR), marker for naive (CD45RA) and primed (CD45RO) cells and the different variable alpha/beta (AV/BV) gene segments on them. The TCR AV/BV repertoire was studied using a panel of 15 T cell receptor (TCR) V-specific MoAbs by flow cytometry in 18 patients and 23 age- and sex-matched controls. Patients had a higher percentage of AV12S1 (P < 0.05), BV6S7 (P < 0.05) and BV9 (P < 0.001)-bearing CD4+ cells. Patients also had a higher frequency of expansions, i.e. of T cell populations with an abnormally high TCR AV/BV gene usage. In patients' CD4+ subset of cells, there were 22 expansions out of 231 analyses (9.5%), whereas in controls, four were expanded out of 310 analyses (1%) (P < 0.001). For CD8+ cells, the frequency of expansions was 32 in 231 analyses (14%) in patients and nine out of 304 analyses in controls (3%) (P < 0.01). In addition, there was a correlation between CD4+ expansions and disease activity; nine out of 10 patients with active disease in comparison with two out of eight patients with inactive disease (P < 0.01) had an expansion. Some of the expanded populations in patients were phenotypically characterized and observed to be HLA-DR+, CD28+, CD45RA+ and CD45RO+, with a greater proportion being CD45RO+. Patients had a higher percentage of expression of HLA-DR on both CD4+ and CD8+ T cells (P < 0.01). The percentages of naive and primed CD4+ and CD8+ T cells, gammadelta+ T cells and natural killer cells were comparable to those in the control group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030862      PMCID: PMC1904564          DOI: 10.1111/j.1365-2249.1997.295-ce1186.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

Review 1.  T cell receptor usage in autoimmune disease.

Authors:  P Moss; J Bell
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Aortic aneurysms: an immune disease with a strong genetic component.

Authors:  Helena Kuivaniemi; Chris D Platsoucas; M David Tilson
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

3.  Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations.

Authors:  B Y Xu; R Giscombe; A Söderlund; M Troye-Blomberg; R Pirskanen; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

4.  A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.

Authors:  Carol A Langford; David Cuthbertson; Steven R Ytterberg; Nader Khalidi; Paul A Monach; Simon Carette; Philip Seo; Larry W Moreland; Michael Weisman; Curry L Koening; Antoine G Sreih; Robert Spiera; Carol A McAlear; Kenneth J Warrington; Christian Pagnoux; Kathleen McKinnon; Lindsy J Forbess; Gary S Hoffman; Renée Borchin; Jeffrey P Krischer; Peter A Merkel
Journal:  Arthritis Rheumatol       Date:  2017-03-08       Impact factor: 10.995

5.  Oligoclonal T cell expansions in patients with Behçet's disease.

Authors:  H Direskeneli; E Eksioglu-Demiralp; A Kibaroglu; S Yavuz; T Ergun; T Akoglu
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

6.  Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis.

Authors:  N Kumar Tripathy; S Kumar Chauhan; S Nityanand
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

7.  The role of CD8+ Granzyme B+ T cells in the pathogenesis of Takayasu's arteritis.

Authors:  Taotao Li; Na Gao; Wei Cui; Limin Zhao; Juan Du; Xuemei Shi; Junming Zhu; Zhiyu Qiao; Shichao Guo; Lili Pan
Journal:  Clin Rheumatol       Date:  2021-09-07       Impact factor: 2.980

8.  Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  M Lopez-Hoyos; M J Bartolome-Pacheco; R Blanco; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

9.  Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity.

Authors:  R Giscombe; S Nityanand; N Lewin; J Grunewald; A K Lefvert
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

10.  Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis.

Authors:  S Kumar Chauhan; N Kumar Tripathy; N Sinha; M Singh; S Nityanand
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.